Rocky S. Tuan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rocky S. Tuan has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Wan-Ju Li
Department of Orthopedics and Rehabilitation, University of Wisconsin-Madison, Madison, USA
2 shared publications - Ahmet Cevik Tufan
University of Health Sciences
1 shared publication Alexander R. Vaccaro
Department of Orthopaedic Surgery, Thomas Jefferson University Hospital, 1015 Walnut Street, Philadelphia, Pennsylvania 19107
1 shared publicationD.J. Hall
Department of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, PA, 19107, U S A
1 shared publicationE. J. Caterson
Department of Orthopaedic Surgery, Thomas Jefferson University, 1015 Walnut Street, Philadelphia, PA 19107, USA
1 shared publicationEdward J. Caterson
Department of Orthopaedic Surgery, Thomas Jefferson University Hospital, 1015 Walnut Street, Philadelphia, Pennsylvania 19107, USA
1 shared publication
Latest Publications
- 1 June 2002
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 961 (1) , 134-138
Polymer/Alginate Amalgam for Cartilage‐ Tissue Engineering
Abstract: Marrow stroma‐derived cells (MSC) are highly proliferative, multipotential cells that have been considered as ideal candidate cells for autologous tissue engineering applications. In this study, we have characterized the chondrogenic potential of human MSCs in both a PLA/alginate amalgam and pure PLA macrostructure as model three‐dimensional constructs to support both chondrogenic differentiation and proliferation following TGF‐β treatment. MSCs were seeded in experimental groups that consisted of PLA‐loaded constructs and PLA/alginate amalgams with and without recombinant human TGF‐β1. Chondrogenesis of the PLA and the PLA/alginate amalgam cultures was assessed at weekly intervals by histology, immunohistochemistry, scanning electron microscopy, sulfate incorporation, and RT‐PCR. Chondrogenic differentiation occurs within a polymeric macrostructure with TGF‐β1 treatment as indicated by histological, immunohistochemical, sulfate incorporation, and gene expression profiles. This macrostructure can be further encased in an alginate gel/solution to optimize cell shape and to confine growth factors and cells within the polymer construct, while the polymeric scaffold provides appropriate mechanical/tissue support. The stable three‐dimensional PLA/alginate amalgam represents a novel candidate system of mesenchymal chondrogenesis, which is amendable to investigation of mechanical and biological factors that normally modulate cartilage development and formation as well as a potential tissue engineering construct for cartilage repair.
- 1 June 2002
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 961 (1) , 134-138
Polymer/Alginate Amalgam for Cartilage‐ Tissue Engineering
Abstract: Marrow stroma‐derived cells (MSC) are highly proliferative, multipotential cells that have been considered as ideal candidate cells for autologous tissue engineering applications. In this study, we have characterized the chondrogenic potential of human MSCs in both a PLA/alginate amalgam and pure PLA macrostructure as model three‐dimensional constructs to support both chondrogenic differentiation and proliferation following TGF‐β treatment. MSCs were seeded in experimental groups that consisted of PLA‐loaded constructs and PLA/alginate amalgams with and without recombinant human TGF‐β1. Chondrogenesis of the PLA and the PLA/alginate amalgam cultures was assessed at weekly intervals by histology, immunohistochemistry, scanning electron microscopy, sulfate incorporation, and RT‐PCR. Chondrogenic differentiation occurs within a polymeric macrostructure with TGF‐β1 treatment as indicated by histological, immunohistochemical, sulfate incorporation, and gene expression profiles. This macrostructure can be further encased in an alginate gel/solution to optimize cell shape and to confine growth factors and cells within the polymer construct, while the polymeric scaffold provides appropriate mechanical/tissue support. The stable three‐dimensional PLA/alginate amalgam represents a novel candidate system of mesenchymal chondrogenesis, which is amendable to investigation of mechanical and biological factors that normally modulate cartilage development and formation as well as a potential tissue engineering construct for cartilage repair.
- 6 December 2001
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 84 (2) , 237-248
Cell density dependent regulation of AP‐1 activity is important for chondrogenic differentiation of C3H10T1/2 mesenchymal cells
The multipotential C3H10T1/2 mesenchymal cells undergo chondrogenic differentiation only when seeded as high‐density micromass cultures, particularly upon treatment with bone morphogenetic protein‐2 (BMP‐2). The molecular mechanism(s) responsible for the cell density‐dependent onset of cartilage‐specific gene expression is presently unknown. Interestingly, a number of recent studies have indicated that activating protein‐1 (AP‐1), a well known downstream target of the mitogenic activated protein kinase (MAP kinase) signaling pathway, is a target of chondrogenic/osteogenic growth factors such as BMP‐2, and plays a role in osteogenic gene regulation as well as in chondrogenic differentiation. The aim of this study is to examine the density‐dependent alteration in the level and binding activity of AP‐1 and its functional involvement in C3H10T1/2 mesenchymal chondrogenesis. To measure the activity of the AP‐1 transcription factor, we generated a pool of stable C3H10T1/2 cell lines harboring a luciferase expression vector driven by a concatamer of an efficient AP‐1 response element (AP1‐10T1/2 cells). Luciferase activity of AP1‐10T1/2 cultures was found to decrease sharply with increase in cell density, either as a function of culture time or initial cell seeding densities. In C3H10T1/2 micromass cultures undergoing chondrogenesis, AP‐1 activity was further reduced and then maintained at a low, steady level for the entire 3–4 day culture period. AP‐1 activity in micromass cultures was not significantly affected by BMP‐2 treatment, but chondrogenesis was compromised upon competitive inhibition of AP‐1 activity with a double‐stranded AP‐1 binding oligonucleotide. The level of AP‐1 binding correlated with the activity of its response element but not with the levels of its leucine‐zipper containing subunits, c‐Jun and c‐Fos. These findings suggest that a cell density‐dependent, low but steady level of AP‐1 binding and activity is required for promoting the chondrogenic potential of C3H10T1/2 cells. J. Cell. Biochem. 84: 237–248, 2002.
- 6 December 2001
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 84 (2) , 237-248
Cell density dependent regulation of AP‐1 activity is important for chondrogenic differentiation of C3H10T1/2 mesenchymal cells
The multipotential C3H10T1/2 mesenchymal cells undergo chondrogenic differentiation only when seeded as high‐density micromass cultures, particularly upon treatment with bone morphogenetic protein‐2 (BMP‐2). The molecular mechanism(s) responsible for the cell density‐dependent onset of cartilage‐specific gene expression is presently unknown. Interestingly, a number of recent studies have indicated that activating protein‐1 (AP‐1), a well known downstream target of the mitogenic activated protein kinase (MAP kinase) signaling pathway, is a target of chondrogenic/osteogenic growth factors such as BMP‐2, and plays a role in osteogenic gene regulation as well as in chondrogenic differentiation. The aim of this study is to examine the density‐dependent alteration in the level and binding activity of AP‐1 and its functional involvement in C3H10T1/2 mesenchymal chondrogenesis. To measure the activity of the AP‐1 transcription factor, we generated a pool of stable C3H10T1/2 cell lines harboring a luciferase expression vector driven by a concatamer of an efficient AP‐1 response element (AP1‐10T1/2 cells). Luciferase activity of AP1‐10T1/2 cultures was found to decrease sharply with increase in cell density, either as a function of culture time or initial cell seeding densities. In C3H10T1/2 micromass cultures undergoing chondrogenesis, AP‐1 activity was further reduced and then maintained at a low, steady level for the entire 3–4 day culture period. AP‐1 activity in micromass cultures was not significantly affected by BMP‐2 treatment, but chondrogenesis was compromised upon competitive inhibition of AP‐1 activity with a double‐stranded AP‐1 binding oligonucleotide. The level of AP‐1 binding correlated with the activity of its response element but not with the levels of its leucine‐zipper containing subunits, c‐Jun and c‐Fos. These findings suggest that a cell density‐dependent, low but steady level of AP‐1 binding and activity is required for promoting the chondrogenic potential of C3H10T1/2 cells. J. Cell. Biochem. 84: 237–248, 2002.
- 16 August 2001
- Published by Wiley in Journal of Biomedical Materials Research
- Vol. 57 (3) , 394-403
Three-dimensional cartilage formation by bone marrow-derived cells seeded in polylactide/alginate amalgam
Bone marrow‐derived cells are considered as candidate cells for cartilage tissue engineering by virtue of their ability to undergo chondrogenesis in vitro when cultured in high density or when embedded within a three‐dimensional matrix in the presence of growth factors. This study evaluated the potential of human bone marrow‐derived cells for cartilage tissue engineering by examining their chondrogenic properties within a three‐dimensional amalgam scaffold consisting of the biodegradable polymer, poly‐L‐lactic acid (PLA) alone, and with the polysaccharide gel, alginate. Cells were suspended either in alginate or medium and loaded into porous PLA blocks. Alginate was used to improve cell loading and retention within the construct, whereas the PLA polymeric scaffold provided appropriate mechanical support and stability to the composite culture. Cells seeded in the PLA/alginate amalgams and the plain PLA constructs were treated with different concentrations of recombinant human transforming growth factor‐β1 (TGF‐β1) either continuously (10 ng/mL) or only for the initial 3 days of culture (50 ng/mL). Chondrogenesis was assessed at weekly intervals with cultures maintained for up to 3 weeks. Histological and immunohistochemical analysis of the TGF‐β1‐treated PLA/alginate amalgam and PLA constructs showed development of a cartilaginous phenotype from day 7 to day 21 as demonstrated by colocalization of Alcian blue staining with collagen type II and cartilage proteoglycan link protein. Expression of cartilage specific genes, including collagen types II and IX, and aggrecan, was detected in TGF‐β1‐treated cultures by reverse transcription‐polymerase chain reaction analysis. The initiation and progression of chondrogenic differentiation within the polymeric macrostructure occurred with both continuous and the initial 3‐day TGF‐β1 treatment regimens, suggesting that key regulatory events of chondrogenesis take place during the early period of cell growth and proliferation. Scanning electron microscopy revealed abundant cells with a rounded morphology in the PLA/alginate amalgam. These findings suggest that the three‐dimensional PLA/alginate amalgam is a potential candidate bioactive scaffold for cartilage tissue engineering applications. © 2001 John Wiley & Sons, Inc. J Biomed Mater Res 57: 394–403, 2001
- 16 August 2001
- Published by Wiley in Journal of Biomedical Materials Research
- Vol. 57 (3) , 394-403
Three-dimensional cartilage formation by bone marrow-derived cells seeded in polylactide/alginate amalgam
Bone marrow‐derived cells are considered as candidate cells for cartilage tissue engineering by virtue of their ability to undergo chondrogenesis in vitro when cultured in high density or when embedded within a three‐dimensional matrix in the presence of growth factors. This study evaluated the potential of human bone marrow‐derived cells for cartilage tissue engineering by examining their chondrogenic properties within a three‐dimensional amalgam scaffold consisting of the biodegradable polymer, poly‐L‐lactic acid (PLA) alone, and with the polysaccharide gel, alginate. Cells were suspended either in alginate or medium and loaded into porous PLA blocks. Alginate was used to improve cell loading and retention within the construct, whereas the PLA polymeric scaffold provided appropriate mechanical support and stability to the composite culture. Cells seeded in the PLA/alginate amalgams and the plain PLA constructs were treated with different concentrations of recombinant human transforming growth factor‐β1 (TGF‐β1) either continuously (10 ng/mL) or only for the initial 3 days of culture (50 ng/mL). Chondrogenesis was assessed at weekly intervals with cultures maintained for up to 3 weeks. Histological and immunohistochemical analysis of the TGF‐β1‐treated PLA/alginate amalgam and PLA constructs showed development of a cartilaginous phenotype from day 7 to day 21 as demonstrated by colocalization of Alcian blue staining with collagen type II and cartilage proteoglycan link protein. Expression of cartilage specific genes, including collagen types II and IX, and aggrecan, was detected in TGF‐β1‐treated cultures by reverse transcription‐polymerase chain reaction analysis. The initiation and progression of chondrogenic differentiation within the polymeric macrostructure occurred with both continuous and the initial 3‐day TGF‐β1 treatment regimens, suggesting that key regulatory events of chondrogenesis take place during the early period of cell growth and proliferation. Scanning electron microscopy revealed abundant cells with a rounded morphology in the PLA/alginate amalgam. These findings suggest that the three‐dimensional PLA/alginate amalgam is a potential candidate bioactive scaffold for cartilage tissue engineering applications. © 2001 John Wiley & Sons, Inc. J Biomed Mater Res 57: 394–403, 2001
- Open Access
- 18 April 2001
- Published by Wiley in The FASEB Journal
- Vol. 15 (8) , 1436-1438
Wnt regulation of limb mesenchymal chondrogenesis is accompanied by altered N‐cadherin‐related functions
It has been suggested that Wnt proteins play essential roles in the regulation of limb development and morphogenesis. We have analyzed the effects of RCAS retroviral‐mediated misexpression of Wnt‐5a and Wnt‐7a, two Wnt genes expressed during normal limb development, on chondrogenesis in high‐density micromass cultures of chick limb bud mesenchymal cells. Wnt‐ 7a misexpression inhibited chondrogenesis in vitro, whereas Wnt‐5a did not. Analysis of cellular condensation and precartilage aggregate formation revealed that the inhibitory effect of Wnt‐7a is unlikely to act at the cellular condensation step but, instead, influences the actual chondrogenic differentiation process. During early condensation, N‐cadherin expression within the cellular aggregates in Wnt‐7a cultures was slightly delayed, whereas Wnt‐5a cultures appeared similar to control cultures. With the initiation of differentiation, Wnt‐5a and control cultures showed down‐ regulation of N‐cadherin and up‐regulation of collagen type II expression, whereas Wnt‐7a cultures showed persistent, high levels of N‐cadherin expression both at the mRNA and protein levels, up to 72 h, and nearly no collagen type II expression. Wnt‐7a misexpression was also accompanied by an initial increase in the serine/threonine phosphorylation of β‐catenin and N‐ cadherin, events known to affect N‐cadherin turnover and stabilization of β‐catenin/N‐cadherin cell adhesion complex, during chondrogenic differentiation. Wnt regulation of limb mesenchymal chondrogenesis is thus likely to involve modulation of N‐cadherin expression and function. In addition, Wnt‐7a misexpression stimulates the proliferation of limb mesenchymal cells in vitro, possibly contributing to its chondro‐inhibitory effect. Finally, the differences between Wnt‐5a and Wnt‐7a effects suggest functional diversity within the Wnt family.
- 18 April 2001
- Published by Wiley in The FASEB Journal
- Vol. 15 (8) , 1436-1438
Open AccessWnt regulation of limb mesenchymal chondrogenesis is accompanied by altered N‐cadherin‐related functions
It has been suggested that Wnt proteins play essential roles in the regulation of limb development and morphogenesis. We have analyzed the effects of RCAS retroviral‐mediated misexpression of Wnt‐5a and Wnt‐7a, two Wnt genes expressed during normal limb development, on chondrogenesis in high‐density micromass cultures of chick limb bud mesenchymal cells. Wnt‐ 7a misexpression inhibited chondrogenesis in vitro, whereas Wnt‐5a did not. Analysis of cellular condensation and precartilage aggregate formation revealed that the inhibitory effect of Wnt‐7a is unlikely to act at the cellular condensation step but, instead, influences the actual chondrogenic differentiation process. During early condensation, N‐cadherin expression within the cellular aggregates in Wnt‐7a cultures was slightly delayed, whereas Wnt‐5a cultures appeared similar to control cultures. With the initiation of differentiation, Wnt‐5a and control cultures showed down‐ regulation of N‐cadherin and up‐regulation of collagen type II expression, whereas Wnt‐7a cultures showed persistent, high levels of N‐cadherin expression both at the mRNA and protein levels, up to 72 h, and nearly no collagen type II expression. Wnt‐7a misexpression was also accompanied by an initial increase in the serine/threonine phosphorylation of β‐catenin and N‐ cadherin, events known to affect N‐cadherin turnover and stabilization of β‐catenin/N‐cadherin cell adhesion complex, during chondrogenic differentiation. Wnt regulation of limb mesenchymal chondrogenesis is thus likely to involve modulation of N‐cadherin expression and function. In addition, Wnt‐7a misexpression stimulates the proliferation of limb mesenchymal cells in vitro, possibly contributing to its chondro‐inhibitory effect. Finally, the differences between Wnt‐5a and Wnt‐7a effects suggest functional diversity within the Wnt family.
- Open Access
- 1 May 2000
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 8 (3) , 236-239
Molecular cloning and expression patterns of mouse cartilage oligomeric matrix protein gene
- 1 May 2000
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 8 (3) , 236-239
Open AccessMolecular cloning and expression patterns of mouse cartilage oligomeric matrix protein gene
- 1 May 1999
- Published by Springer Nature in In Vitro Cellular & Developmental Biology - Animal
- Vol. 35 (5) , 262-269
High density micromass cultures of embryonic limb bud mesenchymal cells: An in vitro model of endochondral skeletal development
To study the mechanisms regulating endochondral skeletal development, we examined the characteristics of long-term, high density micromass cultures of embryonic chicken limb bud mesenchymal cells. By culture Day 3, these cells underwent distinct chondrogenesis, evidenced by cellular condensation to form large nodules exhibiting cartilage-like morphology and extracellular matrix. By Day 14, extensive cellular hypertrophy was seen in the core of the nodules, accompanied by increased alkaline phosphatase activity, and the limitation of cellular proliferation to the periphery of the nodules and to internodular areas. By Day 14, matrix calcification was detected by alizarin red staining, and calcium incorporation increased as a function of culture time up to 2 to 3 wk and then decreased. X-ray probe elemental analysis detected the presence of hydroxyapatite. Analogous to growth cartilage developing in vivo, these cultures also exhibited time-dependent apoptosis, on the basis of DNA fragmentation detected in situ by terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate (dUTP) nick end labeling (TUNEL), ultrastructural nuclear morphology, and the appearance of internucleosomal DNA degradation. These findings showed that cellular differentiation, maturation, hypertrophy, calcification, and apoptosis occurred sequentially in the embryonic limb mesenchyme micromass cultures and indicate their utility as a convenient in vitro model to investigate the regulatory mechanisms of endochondral ossification.
- 1 May 1999
- Published by Springer Nature in In Vitro Cellular & Developmental Biology - Animal
- Vol. 35 (5) , 262-269
High density micromass cultures of embryonic limb bud mesenchymal cells: An in vitro model of endochondral skeletal development
To study the mechanisms regulating endochondral skeletal development, we examined the characteristics of long-term, high density micromass cultures of embryonic chicken limb bud mesenchymal cells. By culture Day 3, these cells underwent distinct chondrogenesis, evidenced by cellular condensation to form large nodules exhibiting cartilage-like morphology and extracellular matrix. By Day 14, extensive cellular hypertrophy was seen in the core of the nodules, accompanied by increased alkaline phosphatase activity, and the limitation of cellular proliferation to the periphery of the nodules and to internodular areas. By Day 14, matrix calcification was detected by alizarin red staining, and calcium incorporation increased as a function of culture time up to 2 to 3 wk and then decreased. X-ray probe elemental analysis detected the presence of hydroxyapatite. Analogous to growth cartilage developing in vivo, these cultures also exhibited time-dependent apoptosis, on the basis of DNA fragmentation detected in situ by terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate (dUTP) nick end labeling (TUNEL), ultrastructural nuclear morphology, and the appearance of internucleosomal DNA degradation. These findings showed that cellular differentiation, maturation, hypertrophy, calcification, and apoptosis occurred sequentially in the embryonic limb mesenchyme micromass cultures and indicate their utility as a convenient in vitro model to investigate the regulatory mechanisms of endochondral ossification.
- 1 March 1999
- Published by Wiley in Developmental Genetics
- Vol. 24 (1-2) , 178-187
N-Cadherin expression and signaling in limb mesenchymal chondrogenesis: Stimulation by Poly-l-Lysine
Cellular condensation is a requisite step in the initiation of mesenchymal chondrogenesis in the embryonic limb bud. We have previously shown that cellular condensation of limb chondroprogenitor mesenchymal cells is accompanied by elevated expression of N‐cadherin during chondrogenesis both in vivo and in vitro. N‐Cadherin‐mediated cell–cell interaction is also functionally required for proper mesenchymal chondrogenesis both in vivo and in vitro. In this report, we have further analyzed the functional importance of N‐cadherin in the cellular condensation–chondrogenesis pathway by examining N‐cadherin expression and related activities in high density micromass cultures of chick limb mesenchymal cells in which chondrogenesis is being stimulated with the cationic polymer, poly‐l‐lysine (PL). The chondrogenesis‐promoting action of PL is thought to involve the clustering of cells via ionic cross‐linking, perhaps mimicking the action of an endogenous matrix component. Immunohistochemistry, immunoblotting, and Northern blot analysis all show that PL treatment results in a time‐dependent increase in N‐cadherin expression at both the protein and mRNA levels. In addition, inhibition of N‐cadherin function with a neutralizing monoclonal antibody directed to its extracellular domain inhibits the chondrogenesis‐stimulating effect of PL. PL treatment also alters the tyrosine‐phosphorylation state of the N‐cadherin associated signaling protein, β‐catenin. These results suggest that N‐cadherin‐mediated cell adhesion is a requisite regulatory component of the limb mesenchymal chondrogenic differentiation program, involving at least in part β‐catenin tyrosine phosphorylation as a signaling step. Dev. Genet. 24:178–187, 1999.
- 1 March 1999
- Published by Wiley in Developmental Genetics
- Vol. 24 (1-2) , 178-187
N-Cadherin expression and signaling in limb mesenchymal chondrogenesis: Stimulation by Poly-l-Lysine
Cellular condensation is a requisite step in the initiation of mesenchymal chondrogenesis in the embryonic limb bud. We have previously shown that cellular condensation of limb chondroprogenitor mesenchymal cells is accompanied by elevated expression of N‐cadherin during chondrogenesis both in vivo and in vitro. N‐Cadherin‐mediated cell–cell interaction is also functionally required for proper mesenchymal chondrogenesis both in vivo and in vitro. In this report, we have further analyzed the functional importance of N‐cadherin in the cellular condensation–chondrogenesis pathway by examining N‐cadherin expression and related activities in high density micromass cultures of chick limb mesenchymal cells in which chondrogenesis is being stimulated with the cationic polymer, poly‐l‐lysine (PL). The chondrogenesis‐promoting action of PL is thought to involve the clustering of cells via ionic cross‐linking, perhaps mimicking the action of an endogenous matrix component. Immunohistochemistry, immunoblotting, and Northern blot analysis all show that PL treatment results in a time‐dependent increase in N‐cadherin expression at both the protein and mRNA levels. In addition, inhibition of N‐cadherin function with a neutralizing monoclonal antibody directed to its extracellular domain inhibits the chondrogenesis‐stimulating effect of PL. PL treatment also alters the tyrosine‐phosphorylation state of the N‐cadherin associated signaling protein, β‐catenin. These results suggest that N‐cadherin‐mediated cell adhesion is a requisite regulatory component of the limb mesenchymal chondrogenic differentiation program, involving at least in part β‐catenin tyrosine phosphorylation as a signaling step. Dev. Genet. 24:178–187, 1999.
- Open Access
- 1 February 1999
- Published by Wiley in Developmental Dynamics
- Vol. 214 (2) , 101-115
Expression of the paired-box genesPax-1 andPax-9 in limb skeleton development
Vertebrate Pax genes encode a family of transcription factors that play important roles in embryonic patterning and morphogenesis. Two closely related Pax genes, Pax‐1 and Pax‐9, are associated with early axial and limb skeleton development. To investigate the role of these genes in cartilage formation we have examined the expression profiles of Pax‐1 and Pax‐9 in developing chick limb mesenchyme in vivo and in vitro. Both transcripts are detected by reverse transcription polymerase chain reaction and Northern blotting throughout chick limb development, from the early bud stages (Hamburger‐Hamilton 20–23) to fully patterned appendages (stage 30). Whole‐mount in situ hybridization reveals complex, nonoverlapping expression domains of these two genes. Pax‐1 transcripts first appear at the anterior proximal margin of the limb buds, while Pax‐9 is expressed more distally at what will be the junction of the autopod and the zeugopod. In situ hybridization to serial sections of the girdles reveals that in the pectoral region Pax‐1 is expressed proximally in condensed mesenchyme surrounding the junction of the developing scapula, humerus, and coracoid. In the pelvis, Pax‐1 is expressed between the femur and the developing acetabulum and along the ventral edge of the ischium; this transcript was also found in the distal hindlimb along the posterior edge of the fibula. Pax‐9 transcripts were not detected in the pectoral girdle at any stage, and only weakly in the pelvis along the ventral ischial margin. In the distal parts of both wings and legs, however, Pax‐9 is strongly expressed between the anterior embryonic cartilages (e.g., distal radius or tibia) and the anterior ectodermal ridge. The expression of both genes was strongest in undifferentiated cells of precartilage condensations or at the margins of differentiated cartilages, and was absent from cartilage itself. In micromass cultures of chondrifying limb bud mesenchyme expression of Pax‐1 and Pax‐9 is maintained for up to 3 days in vitro, most strongly at the end of the culture period during chondrogenic differentiation. As seen in vivo, transcripts are found in loose mesenchyme cells at the outer margins of developing cartilage nodules, and are absent from differentiated chondrocytes at the nodule center. Taken together, these investigations extend previous studies of Pax‐1 and Pax‐9 expression in embryonic limb development while validating limb bud mesenchyme culture as an accessible experimental system for the study of Pax gene function and regulation. Our in vivo and in vitro observations are discussed with reference to 1) the relationship between somitic and limb expression of these two Pax genes, 2) what regulates this expression in different regions of the embryo, and 3) the putative cellular functions of Pax‐1 and Pax‐9 in embryonic skeletogenesis. Dev Dyn 1999;214:101–115.
- 1 February 1999
- Published by Wiley in Developmental Dynamics
- Vol. 214 (2) , 101-115
Open AccessExpression of the paired-box genesPax-1 andPax-9 in limb skeleton development
Vertebrate Pax genes encode a family of transcription factors that play important roles in embryonic patterning and morphogenesis. Two closely related Pax genes, Pax‐1 and Pax‐9, are associated with early axial and limb skeleton development. To investigate the role of these genes in cartilage formation we have examined the expression profiles of Pax‐1 and Pax‐9 in developing chick limb mesenchyme in vivo and in vitro. Both transcripts are detected by reverse transcription polymerase chain reaction and Northern blotting throughout chick limb development, from the early bud stages (Hamburger‐Hamilton 20–23) to fully patterned appendages (stage 30). Whole‐mount in situ hybridization reveals complex, nonoverlapping expression domains of these two genes. Pax‐1 transcripts first appear at the anterior proximal margin of the limb buds, while Pax‐9 is expressed more distally at what will be the junction of the autopod and the zeugopod. In situ hybridization to serial sections of the girdles reveals that in the pectoral region Pax‐1 is expressed proximally in condensed mesenchyme surrounding the junction of the developing scapula, humerus, and coracoid. In the pelvis, Pax‐1 is expressed between the femur and the developing acetabulum and along the ventral edge of the ischium; this transcript was also found in the distal hindlimb along the posterior edge of the fibula. Pax‐9 transcripts were not detected in the pectoral girdle at any stage, and only weakly in the pelvis along the ventral ischial margin. In the distal parts of both wings and legs, however, Pax‐9 is strongly expressed between the anterior embryonic cartilages (e.g., distal radius or tibia) and the anterior ectodermal ridge. The expression of both genes was strongest in undifferentiated cells of precartilage condensations or at the margins of differentiated cartilages, and was absent from cartilage itself. In micromass cultures of chondrifying limb bud mesenchyme expression of Pax‐1 and Pax‐9 is maintained for up to 3 days in vitro, most strongly at the end of the culture period during chondrogenic differentiation. As seen in vivo, transcripts are found in loose mesenchyme cells at the outer margins of developing cartilage nodules, and are absent from differentiated chondrocytes at the nodule center. Taken together, these investigations extend previous studies of Pax‐1 and Pax‐9 expression in embryonic limb development while validating limb bud mesenchyme culture as an accessible experimental system for the study of Pax gene function and regulation. Our in vivo and in vitro observations are discussed with reference to 1) the relationship between somitic and limb expression of these two Pax genes, 2) what regulates this expression in different regions of the embryo, and 3) the putative cellular functions of Pax‐1 and Pax‐9 in embryonic skeletogenesis. Dev Dyn 1999;214:101–115.